追求成长股长期收益 5只基金连续7年成绩优秀

Core Viewpoint - Growth-style funds have achieved significant excess returns in 2023, driven by sectors such as AI, innovative pharmaceuticals, and the Beijing Stock Exchange [1] Group 1: Growth Funds Performance - Approximately 40 actively managed equity funds have recorded over 100% returns year-to-date, primarily investing in technology and innovative pharmaceutical sectors [1] - The Zhongzheng Taibao Active Equity Growth Fund Index serves as a benchmark for growth-style funds, with only five funds outperforming it for seven consecutive years since 2019 [1] - The performance of growth funds indicates the stability of fund managers' investment styles and the sustainability of good performance [1] Group 2: Fund Management and Strategy - Guangfa Xinyi, managed by Fei Yi since August 2018, has achieved a cumulative return of 289.16% from 2019 to September 30, 2023, with an excess return of 161.03% relative to the Zhongzheng Taibao Growth Index [2] - Fei Yi focuses on long-term trends in economic growth, emphasizing manufacturing and consumption upgrades, particularly in electronics and pharmaceuticals [2] - The fund has maintained a long-term allocation to growth sectors such as electronics, power equipment, and biomedicine, with electronics consistently comprising over 30% of the portfolio since 2021 [2] Group 3: Semiconductor and AI Focus - The semiconductor industry is viewed as having a long-term investment logic, with a focus on domestic substitution and low current domestic production ratios [3] - Fei Yi plans to concentrate on chip design companies, anticipating significant investment opportunities and performance elasticity in this sector [3] - The impact of AI on the electronics industry is also a key focus, with expectations for future innovations despite the current lack of a dominant AI application [3]